Trial Profile
Examining Vaccine Effectiveness (VE) of Flublok Relative to Standard Dose Inactivated Influenza Vaccine Among Kaiser Permanente Northern California Members Aged 18-64 Years
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Mar 2023
Price :
$35
*
At a glance
- Drugs Influenza virus RIV4 vaccine-(FluBlok Quadrivalent) (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Therapeutic Use
- 27 Feb 2023 Status changed from active, no longer recruiting to completed.
- 14 Feb 2022 Planned End Date changed from 31 May 2022 to 31 Dec 2022.
- 14 Feb 2022 Status changed from recruiting to active, no longer recruiting.